Modified release formulations of memantine oral dosage forms | Patent Number 08039009

US 08039009 B2
Application Number11155330
Publication NumberUS 20060051416 A1
Pendency6 years, 4 months, 5 days
Filled DateJun 16, 2005
Priority DateJun 17, 2004
Publication DateMar 9, 2006
Expiration DateJun 17, 2024
Inventor/ApplicantsAntonia Periclou
Shashank Mahashabde
Wattanaporn Abramowitz
Niranjan Rao
Suneel K. Rastogi
Mahendra G. Dedhiya
ExaminesSTONE, CHRISTOPHER R
Art Unit1628
Technology Center1600
Assignments
Allergan
Current
AllerganAbbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.